These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6838359)

  • 41. Gastroesophageal reflux disease and patterns of reflux in patients with idiopathic pulmonary fibrosis using hypopharyngeal multichannel intraluminal impedance.
    Hoppo T; Komatsu Y; Jobe BA
    Dis Esophagus; 2014 Aug; 27(6):530-7. PubMed ID: 23107023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired visceral sensitivity to acid reflux in patients with Barrett's esophagus. The role of esophageal motility*.
    Byrne PJ; Mulligan ED; O'Riordan J; Keeling PW; Reynolds JV
    Dis Esophagus; 2003; 16(3):199-203. PubMed ID: 14641309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury.
    Patti MG; Goldberg HI; Arcerito M; Bortolasi L; Tong J; Way LW
    Am J Surg; 1996 Jan; 171(1):182-6. PubMed ID: 8554137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The real value of lower esophageal sphincter measurement for predicting acid gastroesophageal reflux or Barrett's esophagus.
    Alonso O; Hernández D; Moreno E; Manrique A; Moreno A; García-Sesma A; Calvo J
    J Gastrointest Surg; 2005; 9(7):973-9. PubMed ID: 16137594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Esophageal motility and impedance characteristics in patients with Barrett's esophagus before and after radiofrequency ablation.
    Hemmink GJ; Alvarez Herrero L; Bogte A; Bredenoord AJ; Bergman JJ; Smout AJ; Weusten BL
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1024-32. PubMed ID: 23708277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Esophageal mucosal damage may promote dysmotility and worsen esophageal acid exposure.
    Meneghetti AT; Tedesco P; Damani T; Patti MG
    J Gastrointest Surg; 2005 Dec; 9(9):1313-7. PubMed ID: 16332488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circadian esophageal motor function in patients with gastroesophageal reflux disease.
    Stein HJ; Eypasch EP; DeMeester TR; Smyrk TC; Attwood SE
    Surgery; 1990 Oct; 108(4):769-77; discussion 777-8. PubMed ID: 2218890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-dimensional imaging of the lower esophageal sphincter in gastroesophageal reflux disease.
    Stein HJ; DeMeester TR; Naspetti R; Jamieson J; Perry RE
    Ann Surg; 1991 Oct; 214(4):374-83; discussion 383-4. PubMed ID: 1953093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High vasoactive intestinal polypeptide plasma levels in patients with Barrett's esophagus.
    Rossiter A; Guelrud M; Souney PF; Mendoza S; Rossiter G; Gelrud D
    Scand J Gastroenterol; 1991 May; 26(5):572-6. PubMed ID: 1871550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barrett's esophagus: clinical, endoscopic, histologic, manometric, and electrical potential difference characteristics.
    Herlihy KJ; Orlando RC; Bryson JC; Bozymski EM; Carney CN; Powell DW
    Gastroenterology; 1984 Mar; 86(3):436-43. PubMed ID: 6693010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical management of Barrett's esophagus.
    Clark GW; DeMeester TR
    Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Manometry and 24-hour ambulatory pH monitoring at two levels of the esophagus in patients with and without esophagitis.
    Sevilla Mantilla MC; Ruiz de León A; Pérez de la Serna J; Taxonera C; García Paredes J; Díaz Rubio M
    Rev Esp Enferm Dig; 1998 Mar; 90(3):145-54. PubMed ID: 9595935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Esophageal motility in Japanese patients with Barrett's esophagus.
    Iwakiri K; Sugiura T; Hayashi Y; Kotoyori M; Kawakami A; Makino H; Nomura T; Miyashita M; Takubo K; Sakamoto C
    J Gastroenterol; 2003; 38(11):1036-41. PubMed ID: 14673719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux.
    Csendes A; Smok G; Burdiles P; Quesada F; Huertas C; Rojas J; Korn O
    Dis Esophagus; 2000; 13(1):5-11. PubMed ID: 11005324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
    Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
    Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Esophageal manometry in gastroesophageal reflux disease. Lower esophageal sphincter incompetence or esophageal dismotility?].
    Valdovinos Díaz MA; Flores C; Facha MT; Koller Lucio J
    Rev Gastroenterol Mex; 1999; 64(1):16-8. PubMed ID: 10532117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Esophageal Function Abnormalities in Patients With Barrett's Esophagus.
    Fass R; Teramoto O; Kurin M; Khalessi A; Kitayama Y; Shibli F
    J Clin Gastroenterol; 2020 Jul; 54(6):485-492. PubMed ID: 32324680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.